Showing results (881-890 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 27, 2022
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical StudiesHarry Fagan, Edward Jones, David S BaldwinCNS Drugs|December 9, 2022
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia DisorderDieter Kunz, Yves Dauvilliers, Heike Benes, et al.CNS Drugs|September 23, 2020
Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain TumorsRianne Haumann, Jessica Carvalho Videira, Gertjan J L Kaspers, et al.CNS Drugs|July 29, 2021
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE StudyGiovanni Castelnovo, Oliver Gerlach, Mark S Freedman, et al.CNS Drugs|May 4, 2016
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current EvidenceSura Alwan, Jan M Friedman, Christina ChambersCNS Drugs|July 17, 2021
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-AnalysisLucas Hendrik Overeem, Bianca Raffaelli, Jasper Mecklenburg, et al.CNS Drugs|July 18, 2021
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' PerspectivesLaurent M Willems, Felix Rosenow, Susanne Schubert-Bast, et al.CNS Drugs|May 19, 2022
Current Principles in the Management of Drug-Resistant EpilepsyNathan A Shlobin, Josemir W SanderCNS Drugs|January 7, 2006
Cataplexy associated with narcolepsy: epidemiology, pathophysiology and managementMichael J ThorpyCNS Drugs|February 19, 2008
Vaccines for multiple sclerosis: progress to dateJorge Correale, Mauricio Farez, Wendy GilmorePageof 211